Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
CG Oncology, Inc. (CGON) had Consolidated Net Income/Loss of $-41.43M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-41.43M |
|
-- |
|
-- |
|
$48.74M |
|
$-48.74M |
|
$7.32M |
|
$-41.43M |
|
$-41.43M |
|
$-41.43M |
|
$-41.43M |
|
|
Consolidated Net Income/Loss |
$-41.43M |
$-41.43M |
|
$-48.74M |
|
$-50.47M |
|
76.23M |
|
76.23M |
|
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$673.03M |
|
$0.25M |
|
$28.41M |
|
$701.45M |
|
$30.38M |
|
-- |
|
$0.71M |
|
$31.09M |
|
$670.36M |
|
$670.36M |
|
$670.36M |
|
76.23M |
|
| Cash Flow Statement Financials | |
$-57.24M |
|
$-185.36M |
|
$0.15M |
|
$257.07M |
|
$14.62M |
|
$-242.44M |
|
$12.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-57.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.18% |
|
-6.18% |
|
-5.91% |
|
-6.18% |
|
$8.79 |
|
$-0.75 |
|
$-0.75 |
|